yield10.png
Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C3003
April 23, 2019 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the...
yield10.png
Yield10 Bioscience CEO Oliver Peoples to Present at the Advanced Bioeconomy Leadership Conference on April 3, 2019
April 02, 2019 08:00 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the...
gmi 2018.png
Gene Editing Market will surge at 14%+ CAGR to hit $7.5 Billion by 2024: Global Market Insights, Inc.
January 23, 2019 04:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Germany gene editing market will register 14.4% CAGR in from 2018 to 2024 and is expected to grow significantly over forecast timeframe....
yield10.png
Yield10 Bioscience Initiates Early Development Program in Corn to Evaluate Novel Traits
January 22, 2019 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global...
yield10.png
Yield10 Bioscience Announces Third Quarter 2018 Financial Results
November 08, 2018 16:02 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global...
yield10.png
Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content
October 02, 2018 08:00 ET | Yield10 Bioscience, Inc.
--USDA-APHIS Response Marks Clearance of Yield10’s First Triple Genome-edited Plant Lines --Favorable Response Accelerates Path to U.S. Field Trials in 2019 WOBURN, Mass., Oct. 02, 2018 (GLOBE...
yield10.png
Yield10 Bioscience Grants Research License to Forage Genetics to Evaluate Novel Yield Traits in Sorghum
September 21, 2018 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 21, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global...
yield10.png
Yield10 Bioscience Announces Second Quarter 2018 Financial Results
August 09, 2018 16:05 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to achieve step-change improvements in crop yield to enhance global...
yield10.png
Yield10 Bioscience Signs Research License Agreement Covering CRISPR-Cas9 Genome-Editing Technology with the Broad Institute and Pioneer
August 08, 2018 08:30 ET | Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield to enhance global food...
GMILogo_Vertical-Gradient.png
Genome Editing Market to grow at 14% CAGR and exceed $7.5 billion by 2024: Global Market Insights, Inc.
August 10, 2017 07:30 ET | Global Market Insights, Inc
Ocean View, Delaware, Aug. 10, 2017 (GLOBE NEWSWIRE) -- The Industry Analysis report “Gene Editing Market By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), Meganucleases, TALENS), By...